IRIS
ZANARDI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.765
AS - Asia 759
NA - Nord America 339
SA - Sud America 77
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.953
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.616
SG - Singapore 346
US - Stati Uniti d'America 320
CN - Cina 197
VN - Vietnam 147
FR - Francia 55
BR - Brasile 53
FI - Finlandia 28
HK - Hong Kong 20
DE - Germania 13
GB - Regno Unito 12
AR - Argentina 11
JP - Giappone 11
MX - Messico 8
CA - Canada 6
IN - India 6
ES - Italia 5
ID - Indonesia 5
IE - Irlanda 5
IQ - Iraq 5
BD - Bangladesh 4
CH - Svizzera 4
PE - Perù 4
PK - Pakistan 4
RU - Federazione Russa 4
AL - Albania 3
JO - Giordania 3
NL - Olanda 3
ZA - Sudafrica 3
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
ET - Etiopia 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
SI - Slovenia 2
UA - Ucraina 2
UY - Uruguay 2
UZ - Uzbekistan 2
AT - Austria 1
BE - Belgio 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
MR - Mauritania 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
PH - Filippine 1
RE - Reunion 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.953
Salva come PNG Salva come JPEG
Città #
Genova 3.352
Genoa 2.022
Rapallo 682
Vado Ligure 535
Singapore 178
San Jose 103
Lauterbourg 50
Ho Chi Minh City 43
Ashburn 37
Hanoi 34
Beijing 31
Council Bluffs 28
Helsinki 28
New York 23
Hong Kong 18
Santa Clara 12
Frankfurt am Main 10
Bordighera 8
Tokyo 8
Los Angeles 7
Haiphong 6
Mexico City 6
Orem 6
Biên Hòa 5
São Paulo 5
Atlanta 4
Dublin 4
Guangzhou 4
Madrid 4
Zurich 4
Amman 3
Amsterdam 3
Chicago 3
City of London 3
Jakarta 3
Mumbai 3
Newark 3
Nuremberg 3
Thái Nguyên 3
Tianjin 3
Tirana 3
Addis Ababa 2
Agawam 2
Bắc Ninh 2
Campagnano di Roma 2
Can Tho 2
Cardiff 2
Da Nang 2
Houston 2
Karachi 2
Lisbon 2
Ljubljana 2
London 2
Milan 2
Montevideo 2
Nantong 2
Ninh Bình 2
Orangeburg 2
Parker 2
Phủ Lý 2
Poplar 2
Porto Alegre 2
Santiago 2
Shanghai 2
Suzhou 2
Tashkent 2
Thái Bình 2
Volta Redonda 2
Vĩnh Long 2
Agadir 1
Agropoli 1
Anchorage 1
Aparecida de Goiânia 1
Aquidauana 1
Araguaiana 1
Asunción 1
Athens 1
Baghdad 1
Barquisimeto 1
Belém 1
Bitonto 1
Blumenau 1
Boston 1
Bowie 1
Brussels 1
Bucharest 1
Buffalo 1
Bến Cầu 1
Caaporã 1
Camacan 1
Camaçari 1
Canoas 1
Cao Lanh 1
Cape Town 1
Catamarca 1
Chalco 1
Charleston 1
Chennai 1
Chiang Mai 1
Ciudad del Este 1
Totale 7.377
Salva come PNG Salva come JPEG
Nome #
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome 244
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. 214
A Case of Plasmacytoid Variant of Bladder Cancer with a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature 202
Androgen-deprivation therapy is more than palliation in oligometastatic prostate cancer 195
Better Together: Targeted Combination Therapies in Breast Cancer 195
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 194
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials 189
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: A mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes 183
Prognostic variables in localized small cell neuroendocrine carcinoma of the bladder: A population-based study 179
Prognostic value of preoperative serum levels of periostin (PN) in early breast cancer (BCa) 178
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer 177
Seasonal and pandemic (A/H1N1 2009) MF-59-adjuvanted influenza vaccines in complete remission non-Hodgkin lymphoma patients previously treated with rituximab containing regimens. 165
Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study 165
May adjuvant therapy play a role for the management of renal cell carcinoma? A review of literature and ongoing trials 165
Targeting androgen-independent pathways: new chances for patients with prostate cancer? 165
Concurrent vs Sequential Adjuvant Chemotherapy and Hormone Therapy in Breast Cancer: A Multicenter Randomized Phase III Trial 163
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma 159
Combinations of hormonal therapy and chemotherapy 158
Bone metastases from prostate cancer: hormonal therapy 158
Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey 157
Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer 150
Cardiovascular disease (CVD) markers in patients(pts) with prostate cancer(PCa) treated with GN-RH agonists(AG) or antagonist(AN): a prospective cohort study 149
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study 148
Patients Treated with Rituximab-Containing Immunochemotherapy Have a Significant and Prolonged Lack of Humoral Response to Influenza Vaccine Associated with a Persistent Depletion of B Memory Cells 147
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients 147
A large SEER- based study of survival trends in patients with de novo metastatic prostate cancer 144
Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era 143
Treatment of elderly patients with metastatic renal cell carcinoma 141
To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone 140
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based Study 139
Abiraterone acetate (AA) in pre- and post-docetaxel (DX) setting for metastatic castration resistant prostate cancer (mCRPC): a monoinstitutional experience focused on cardiovascular events and on their impact on clinical outcomes 135
Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223 135
861P Time to castration resistant prostate cancer (CRPC) and the risk of developing immune disorders 130
Insights from a long-term follow-up evaluation of early breast cancer (BC) outcomes by tumor subtype (TS) 124
Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life: A single institution experience 123
BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications 120
Better Together: Immunotherapy as Future Combination Strategy for Breast Cancer 119
EFFICACY AND SAFETY OF SUNITINIB AND EVEROLIMUS AS FRONTLINE TREATMENT FOR NON-CC-RCC: A POOLED-ANALYSIS FROM RANDOMIZED TRIALS 118
Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival 117
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial 115
Beyond the Prognostic Value of 2-[18F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management 114
Risks and benefits from CDK inhibitors for advanced HR+ Her 2- breast cancer 114
First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (NEO) adjuvant trastuzumab 111
Baseline 18F-Fluoride PET-derived parameters predict modification of toxicity-and response-related blood biomarkers in prostate cancer patients treated with 223Ra-Dichloride: preliminary results 111
First line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients (MBC) presenting with de novo or recurrent disease 108
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer 104
Combination therapy in metastatic renal cell carcinoma: Back to the future? 100
Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223 100
Management of advanced endometrial cancer 98
Real-world survival improvements in patients with newly diagnosed metastatic prostate cancer treated in the United States 98
HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature 96
Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases 96
Dose calculation and tolerability of adjuvant AUC 7 carboplatin in 100 patients with stage I seminoma 96
Long-term results from INT-HER study: Retrospective evaluation of adjuvant trastuzumab in unselected HER2-positive breast cancer patients—Single institution experience 90
Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives 89
Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients 73
Cardiac Metastasis from Prostate Cancer: A Case Study Underlying the Crucial Role of the PSMA PET/CT 70
SUNITINIB IN METASTATIC RENAL CELL CARCINOMA: RESULTS OF A MONOCENTRIC EXPERIENCE 55
Neoplasie prostatiche 52
Role of FDG PET/CT in the prognostic stratification and response assessment of castration-resistant prostate cancer treated with radium-223 dichloride 51
null 40
Totale 8.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.756
article - articoli 25.838
book - libri 0
conference - conferenze 438
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.480
Totale 55.512
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021182 0 0 0 0 0 0 0 0 0 80 48 54
2021/2022713 23 24 39 75 29 73 15 147 75 76 43 94
2022/2023778 58 82 11 77 141 128 0 64 122 5 80 10
2023/2024450 12 57 11 57 28 85 24 27 22 27 30 70
2024/20251.423 36 87 45 110 158 148 124 297 38 65 144 171
2025/20261.962 299 73 137 150 349 137 350 92 151 224 0 0
Totale 8.155